229 related articles for article (PubMed ID: 22413002)
1. Coordinated expression of tristetraprolin post-transcriptionally attenuates mitogenic induction of the oncogenic Ser/Thr kinase Pim-1.
Mahat DB; Brennan-Laun SE; Fialcowitz-White EJ; Kishor A; Ross CR; Pozharskaya T; Rawn JD; Blackshear PJ; Hassel BA; Wilson GM
PLoS One; 2012; 7(3):e33194. PubMed ID: 22413002
[TBL] [Abstract][Full Text] [Related]
2. Expression of proviral integration site for Moloney murine leukemia virus 1 (Pim-1) is post-transcriptionally regulated by tristetraprolin in cancer cells.
Kim HK; Kim CW; Vo MT; Lee HH; Lee JY; Yoon NA; Lee CY; Moon CH; Min YJ; Park JW; Cho WJ
J Biol Chem; 2012 Aug; 287(34):28770-8. PubMed ID: 22700982
[TBL] [Abstract][Full Text] [Related]
3. RNase L attenuates mitogen-stimulated gene expression via transcriptional and post-transcriptional mechanisms to limit the proliferative response.
Brennan-Laun SE; Li XL; Ezelle HJ; Venkataraman T; Blackshear PJ; Wilson GM; Hassel BA
J Biol Chem; 2014 Nov; 289(48):33629-43. PubMed ID: 25301952
[TBL] [Abstract][Full Text] [Related]
4. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways.
Deleault KM; Skinner SJ; Brooks SA
Mol Immunol; 2008 Jan; 45(1):13-24. PubMed ID: 17606294
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
[TBL] [Abstract][Full Text] [Related]
6. Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolin.
Qian X; Ning H; Zhang J; Hoft DF; Stumpo DJ; Blackshear PJ; Liu J
J Immunol; 2011 Jun; 186(11):6454-64. PubMed ID: 21515794
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1α mRNA: a new target for destabilization by tristetraprolin in endothelial cells.
Chamboredon S; Ciais D; Desroches-Castan A; Savi P; Bono F; Feige JJ; Cherradi N
Mol Biol Cell; 2011 Sep; 22(18):3366-78. PubMed ID: 21775632
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment.
Clement SL; Scheckel C; Stoecklin G; Lykke-Andersen J
Mol Cell Biol; 2011 Jan; 31(2):256-66. PubMed ID: 21078877
[TBL] [Abstract][Full Text] [Related]
9. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts.
Lai WS; Parker JS; Grissom SF; Stumpo DJ; Blackshear PJ
Mol Cell Biol; 2006 Dec; 26(24):9196-208. PubMed ID: 17030620
[TBL] [Abstract][Full Text] [Related]
10. The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway.
Brooks SA; Connolly JE; Rigby WF
J Immunol; 2004 Jun; 172(12):7263-71. PubMed ID: 15187101
[TBL] [Abstract][Full Text] [Related]
11. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay.
Ogilvie RL; Abelson M; Hau HH; Vlasova I; Blackshear PJ; Bohjanen PR
J Immunol; 2005 Jan; 174(2):953-61. PubMed ID: 15634918
[TBL] [Abstract][Full Text] [Related]
12. Tristetraprolin (TTP) coordinately regulates primary and secondary cellular responses to proinflammatory stimuli.
Qiu LQ; Lai WS; Bradbury A; Zeldin DC; Blackshear PJ
J Leukoc Biol; 2015 Apr; 97(4):723-36. PubMed ID: 25657290
[TBL] [Abstract][Full Text] [Related]
13. Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action.
Brooks SA; Blackshear PJ
Biochim Biophys Acta; 2013; 1829(6-7):666-79. PubMed ID: 23428348
[TBL] [Abstract][Full Text] [Related]
14. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X
Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523
[TBL] [Abstract][Full Text] [Related]
15. Tristetraprolin impairs NF-kappaB/p65 nuclear translocation.
Schichl YM; Resch U; Hofer-Warbinek R; de Martin R
J Biol Chem; 2009 Oct; 284(43):29571-81. PubMed ID: 19654331
[TBL] [Abstract][Full Text] [Related]
16. The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself.
Tchen CR; Brook M; Saklatvala J; Clark AR
J Biol Chem; 2004 Jul; 279(31):32393-400. PubMed ID: 15187092
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of protein kinase Cdelta reduces tristetraprolin expression by destabilizing its mRNA in activated macrophages.
Leppänen T; Jalonen U; Korhonen R; Tuominen RK; Moilanen E
Eur J Pharmacol; 2010 Feb; 628(1-3):220-5. PubMed ID: 19925787
[TBL] [Abstract][Full Text] [Related]
18. Tristetraprolin regulates CXCL1 (KC) mRNA stability.
Datta S; Biswas R; Novotny M; Pavicic PG; Herjan T; Mandal P; Hamilton TA
J Immunol; 2008 Feb; 180(4):2545-52. PubMed ID: 18250465
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin.
Horner TJ; Lai WS; Stumpo DJ; Blackshear PJ
Mol Cell Biol; 2009 Apr; 29(8):1999-2010. PubMed ID: 19188452
[TBL] [Abstract][Full Text] [Related]
20. Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3' untranslated region.
Zhao W; Liu M; D'Silva NJ; Kirkwood KL
J Interferon Cytokine Res; 2011 Aug; 31(8):629-37. PubMed ID: 21457063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
